A research filter, not a predictor — not financial advice. Grades rank growth stocks on evidence-based quality signals from end-of-day data; they are not buy/sell calls or price forecasts. Always do your own research.
Neuronetics, Inc. STIM
Mixed broader-coverage candidate · Neuronetics, Inc. functions as a medical technology enterprise with commercialized products, specializing in the creation, enhancement, and global distribution of solutions for ind
On FrontierLab's discovery record since 2026-08-11 (10 days ago) — when this name first surfaced. (distinct from the snapshot date below)
Auto-graded broader coverage — sourced by an automated screen and graded on default bands, not the sector-calibrated bands the curated screener uses. A "Mixed" here is NOT the same bar as a curated grade; these are auto-screened candidates for your own research, shown as of their surface date (2026-08-12), not the curated Frontier signal.
⚡ Surfaced on a price move — momentum is where to look, not a buy signal. The move that surfaced this name does not make it a good entry.
⚠ Pump risk: parabolic/spike characteristics detected in the screen flags. Treat any positive grade with extra skepticism.
Key quality signals
| Revenue growth (YoY) | 39.6% |
|---|---|
| Gross margin | 49.1% |
| Gross profits / assets | 0.58 |
| Rule of 40 | 24.9 |
| Net margin | -14.7% |
| Cash runway (months) | 25.2 |
| PEG | — |
| Price / sales | 1.4 |
Quality checklist
- ✓ Revenue growth — 39.6% (pass ≥ 20%)
- ✓ Gross profits / assets — 0.58 (pass ≥ 0.33)
- ~ Gross margin — 49.1% (pass ≥ 60%)
- ~ Cash generation
- ✗ Share dilution — 7.8%
Fundamentals — snapshot as of 2026-08-12
| Stage | Established |
|---|---|
| Share issuance (YoY) | 7.8% · heavy issuance |
| Moat | — |
| TAM | — |
| P/E (trailing) | — |
| EPS (trailing) | $-0.43 |
| Burn multiple | 0.1 |
| Gross-margin trend (pts) | -7.1 |
| Cash / assets | 0.15 |
| Net debt / EBITDA | — |
| Statements as of | Q2 FY2026 · filed 2026-08-11 |
Momentum context — a snapshot from 2026-08-12, not current
| Price at surface | $3.19 (as of 2026-08-12) |
|---|---|
| 52-week range | $0.8 – $3.98 |
| % off 52-wk high | -19.8% |
| RSI (14) | 77 |
| Relative volume | 7.8× |
Risk flags
← All broader-coverage names · Curated names → · Open the interactive screener →
Data as of 2026-08-12 (end-of-day). How grades are computed →